NEWS: "Hot Off the Press"
- Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
- Safety Shot Announces Notice of Allowance for New Patent to Secure IP and Enforce Clinically Backed Claims
- Why School Safety Technology Is the Next Big Thing in Investment
- Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
- Safety Shot President Jordan Schur Invests an Additional $3.4 Million in the Company Through His Family Fund, Core 4 Capital Corp.
- Genprex Announces Plans to Launch Separate Company to Focus on the Development of Gene Therapy to Treat Type-1 and Type-2 Diabetes
- Genprex to Present and Participate at Upcoming September Investor and Industry Conferences
- Green Leaf Innovations, Inc. Amplifies Growth Strategy With Debt Reduction, Strategic Acquisitions, and Enhanced Financial Transparency
- Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
- Safety Shot Clinical Data Results Confirm Breakthrough in Dramatic Reduction of Morning-After Symptoms Associated with Excessive Drinking
- Safety Shot Announces Partnership with Digital Growth Platform VENDO
- Green Leaf Innovations, Inc. Advances Debt Reduction Strategy, Strengthening Shareholder Value
- Green Leaf Innovations, Inc. Signs Letter of Intent to Acquire SOFLO Wholesaler Group, Inc., Expanding Market Presence
- Green Leaf Innovations, Inc. Takes Strategic Steps to Enhance Shareholder Value by Reducing Convertible Debt
- Reports Fiscal Year 2024 Financial Results
- Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive Patient Outcomes in Two Lung Cancer Clinical Trials
- Winners Waygers AI Powered Sports Handicapping Assistant Launched In Beta
- Genprex Announces Positive Clinical Study Updates from Acclaim-1 and Acclaim-3 Phase 1/2 Clinical Trials in Lung Cancer
- Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024
- Ascent Solar Technologies Details Financial and Industry Status After Reverse Stock Split
- Ascent Solar Technologies Announces Reverse Stock Split
- Genprex Granted Patent in Singapore for Reqorsa® Gene Therapy with PD-1 Antibodies to Treat Cancers
- Genprex to Present at the August Sidoti Microcap Conference
- The Junk in Your Index Fund Is Costing You Big-Time
- Ascent Solar Technologies CEO to Attend and Present at Key Industry and Investor Events
- CCSC Technology International Holdings Full Year 2024 Earnings: US$0.13 loss per share (vs US$0.22 profit in FY 2023)
- CCSC Technology International Holdings Limited Reports Financial Results for Fiscal Year 2024
- The Big Biz Show interviews Jonathan C. Javitt, M.D., M.P.H./Chief Scientist, Director, and Founder, NRx Pharmaceuticals
- Safety Shot Terminates Partnership With Brand Ambassador Ryan Garcia Following Disparaging Remarks
- Category V Biotech, Inc. Announces Exclusive Licensing of Genetic Networks’ Intellectual Property for Cannabis Applications
- Safety Shot President Jordan Schur Invests $1 Million in the Company Through his Family Fund, Core 4 Capital Corp.
- Cytta Corp’s Entry into the Drone Reseller Market: A Strategic Move for Investors
- Comedian and Actor Drew "Druski" Desbordes Joins Safety Shot as Their Newest Brand Ambassador
- Genprex Issues Stockholder Letter and Provides 2024 Corporate Update
- Green Leaf Innovations, Inc. Expands International Presence with New Partnership in Dubai
- Ascent Solar Technologies Announces Debt Pay Off for Outstanding Balances
- CCSC Technology International Holdings Limited Enters into International Purchase Agreement with SHI / LIGHTCARE-SOLUTIONS ApS
- Renovaro, Inc. Announces $10 million in Equity Committed
- Visionary on the Move
- GV Regains Compliance with Nasdaq Minimum Bid Price Requirement
